Literature DB >> 31527310

mTORC1 feedback to AKT modulates lysosomal biogenesis through MiT/TFE regulation.

Kaushal Asrani1, Sanjana Murali1, Brandon Lam1, Chan-Hyun Na2, Pornima Phatak3, Akshay Sood1, Harsimar Kaur1, Zoya Khan1, Michaël Noë1, Ravi K Anchoori1, C Conover Talbot4, Barbara Smith5, Michael Skaro1, Tamara L Lotan1.   

Abstract

The microphthalmia family of transcription factors (MiT/TFEs) controls lysosomal biogenesis and is negatively regulated by the nutrient sensor mTORC1. However, the mechanisms by which cells with constitutive mTORC1 signaling maintain lysosomal catabolism remain to be elucidated. Using the murine epidermis as a model system, we found that epidermal Tsc1 deletion resulted in a phenotype characterized by wavy hair and curly whiskers, and was associated with increased EGFR and HER2 degradation. Unexpectedly, constitutive mTORC1 activation with Tsc1 loss increased lysosomal content via upregulated expression and activity of MiT/TFEs, whereas genetic deletion of Rheb or Rptor or prolonged pharmacologic mTORC1 inactivation had the reverse effect. This paradoxical increase in lysosomal biogenesis by mTORC1 was mediated by feedback inhibition of AKT, and a resulting suppression of AKT-induced MiT/TFE downregulation. Thus, inhibiting hyperactive AKT signaling in the context of mTORC1 loss-of-function fully restored MiT/TFE expression and activity. These data suggest that signaling feedback loops work to restrain or maintain cellular lysosomal content during chronically inhibited or constitutively active mTORC1 signaling, respectively, and reveal a mechanism by which mTORC1 regulates upstream receptor tyrosine kinase signaling.

Entities:  

Keywords:  Genetic diseases; Lysosomes; Metabolism; Oncology

Mesh:

Substances:

Year:  2019        PMID: 31527310      PMCID: PMC6877313          DOI: 10.1172/JCI128287

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  62 in total

1.  Phosphoproteomic analysis identifies Grb10 as an mTORC1 substrate that negatively regulates insulin signaling.

Authors:  Yonghao Yu; Sang-Oh Yoon; George Poulogiannis; Qian Yang; Xiaoju Max Ma; Judit Villén; Neil Kubica; Gregory R Hoffman; Lewis C Cantley; Steven P Gygi; John Blenis
Journal:  Science       Date:  2011-06-10       Impact factor: 47.728

2.  Protein kinase C controls lysosome biogenesis independently of mTORC1.

Authors:  Yang Li; Meng Xu; Xiao Ding; Chen Yan; Zhiqin Song; Lianwan Chen; Xiahe Huang; Xin Wang; Youli Jian; Guihua Tang; Changyong Tang; Yingtong Di; Shuzhen Mu; Xuezhao Liu; Kai Liu; Ting Li; Yingchun Wang; Long Miao; Weixiang Guo; Xiaojiang Hao; Chonglin Yang
Journal:  Nat Cell Biol       Date:  2016-09-12       Impact factor: 28.824

3.  Rheb1 is required for mTORC1 and myelination in postnatal brain development.

Authors:  Jia Zou; Liang Zhou; Xiao-Xia Du; Yifei Ji; Jia Xu; Junlong Tian; Wanxiang Jiang; Yi Zou; Shouyang Yu; Lingxue Gan; Maowen Luo; Qiaona Yang; Yiyuan Cui; Wanchun Yang; Xiaoqiang Xia; Mina Chen; Xia Zhao; Ying Shen; Po Yu Chen; Paul F Worley; Bo Xiao
Journal:  Dev Cell       Date:  2011-01-18       Impact factor: 12.270

Review 4.  Mechanisms of abnormal lamellar body secretion and the dysfunctional skin barrier in patients with atopic dermatitis.

Authors:  Peter M Elias; Joan S Wakefield
Journal:  J Allergy Clin Immunol       Date:  2014-08-15       Impact factor: 10.793

5.  The transcription factor TFEB links mTORC1 signaling to transcriptional control of lysosome homeostasis.

Authors:  Agnes Roczniak-Ferguson; Constance S Petit; Florian Froehlich; Sharon Qian; Jennifer Ky; Brittany Angarola; Tobias C Walther; Shawn M Ferguson
Journal:  Sci Signal       Date:  2012-06-12       Impact factor: 8.192

6.  Neuronal Tsc1/2 complex controls autophagy through AMPK-dependent regulation of ULK1.

Authors:  Alessia Di Nardo; Mary H Wertz; Erica Kwiatkowski; Peter T Tsai; Jarrett D Leech; Emily Greene-Colozzi; June Goto; Pelin Dilsiz; Delia M Talos; Clary B Clish; David J Kwiatkowski; Mustafa Sahin
Journal:  Hum Mol Genet       Date:  2014-03-05       Impact factor: 6.150

7.  TSC1 stabilizes TSC2 by inhibiting the interaction between TSC2 and the HERC1 ubiquitin ligase.

Authors:  Huira Chong-Kopera; Ken Inoki; Yong Li; Tianqing Zhu; Francesc R Garcia-Gonzalo; Jose Luis Rosa; Kun-Liang Guan
Journal:  J Biol Chem       Date:  2006-02-07       Impact factor: 5.157

Review 8.  Beyond wavy hairs: the epidermal growth factor receptor and its ligands in skin biology and pathology.

Authors:  Marlon R Schneider; Sabine Werner; Ralf Paus; Eckhard Wolf
Journal:  Am J Pathol       Date:  2008-06-13       Impact factor: 4.307

9.  Aberrant differentiation of Tsc2-deficient teratomas associated with activation of the mTORC1-TFE3 pathway.

Authors:  Haruna Kawano; Yoshitaka Ito; Fumio Kanai; Eri Nakamura; Norihiro Tada; Setsuo Takai; Shigeo Horie; Toshiyuki Kobayashi; Okio Hino
Journal:  Oncol Rep       Date:  2015-09-08       Impact factor: 3.906

10.  mTOR-dependent phosphorylation controls TFEB nuclear export.

Authors:  Gennaro Napolitano; Alessandra Esposito; Heejun Choi; Maria Matarese; Valerio Benedetti; Chiara Di Malta; Jlenia Monfregola; Diego Luis Medina; Jennifer Lippincott-Schwartz; Andrea Ballabio
Journal:  Nat Commun       Date:  2018-08-17       Impact factor: 14.919

View more
  8 in total

1.  A dual-targeted molecular therapy of PP242 and cetuximab plays an anti-tumor effect through EGFR downstream signaling pathways in colorectal cancer.

Authors:  Linghui Kong; Qun Zhang; Jialei Mao; Lei Cheng; Xiao Shi; Lixia Yu; Jing Hu; Mi Yang; Li Li; Baorui Liu; Xiaoping Qian
Journal:  J Gastrointest Oncol       Date:  2021-08

2.  Microglial mTOR Activation Upregulates Trem2 and Enhances β-Amyloid Plaque Clearance in the 5XFAD Alzheimer's Disease Model.

Authors:  Qian Shi; Cheng Chang; Afaf Saliba; Manzoor A Bhat
Journal:  J Neurosci       Date:  2022-06-07       Impact factor: 6.709

3.  The expression and significance of mTORC1 in diabetic retinopathy.

Authors:  Yanli Liu; Yarong Zheng; Yekai Zhou; Yi Liu; Mengxuan Xie; Wenjing Meng; Meixia An
Journal:  BMC Ophthalmol       Date:  2020-07-20       Impact factor: 2.209

Review 4.  Lysosomal dysfunction-induced autophagic stress in diabetic kidney disease.

Authors:  Hui Juan Zheng; Xueqin Zhang; Jing Guo; Wenting Zhang; Sinan Ai; Fan Zhang; Yaoxian Wang; Wei Jing Liu
Journal:  J Cell Mol Med       Date:  2020-06-25       Impact factor: 5.310

5.  GPNMB expression identifies TSC1/2/mTOR-associated and MiT family translocation-driven renal neoplasms.

Authors:  Daniela C Salles; Kaushal Asrani; Juhyung Woo; Thiago Vidotto; Hans B Liu; Igor Vidal; Andres Matoso; George J Netto; Pedram Argani; Tamara L Lotan
Journal:  J Pathol       Date:  2022-03-29       Impact factor: 9.883

6.  AAA + ATPase Thorase inhibits mTOR signaling through the disassembly of the mTOR complex 1.

Authors:  George K E Umanah; Leire Abalde-Atristain; Mohammed Repon Khan; Jaba Mitra; Mohamad Aasif Dar; Melissa Chang; Kavya Tangella; Amy McNamara; Samuel Bennett; Rong Chen; Vasudha Aggarwal; Marisol Cortes; Paul F Worley; Taekjip Ha; Ted M Dawson; Valina L Dawson
Journal:  Nat Commun       Date:  2022-08-17       Impact factor: 17.694

Review 7.  Role of mTOR Signaling Cascade in Epidermal Morphogenesis and Skin Barrier Formation.

Authors:  Juan Wang; Sabine A Eming; Xiaolei Ding
Journal:  Biology (Basel)       Date:  2022-06-19

Review 8.  Organelle Cooperation in Stem Cell Fate: Lysosomes as Emerging Regulators of Cell Identity.

Authors:  Lisa M Julian; William L Stanford
Journal:  Front Cell Dev Biol       Date:  2020-07-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.